Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Profit & Loss 
Valuation 
Analyst Note 
Balance Sheet 
Cash Flow 
Financial Ratio 
Qtr. Results 
News 
About
Alembic Ltd (ALEMBICLTD)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506235 NSE: ALEMBICLTD Construction - Real Estate | Small Cap | Alembic Share Price
₹88.51 -0.98 (-1.10%)
As on 17-Jul'26 16:59
Alembic Ltd (ALEMBICLTD)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506235 NSE: ALEMBICLTD Construction - Real Estate | Small Cap | Alembic Share Price
₹88.51 -0.98 (-1.10%)
As on 17-Jul'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹2,273 Cr.
Current Price
₹88.5
52-Week Low / High
₹71 / 122
TTM EPS
₹12.4
TTM Sales
₹240 Cr.
Book Value per Share
₹95.2
P/E Ratio
7.16
Lower than its 5-year historical median
Industry PE
49.3
Price to Book (P/B)
0.93
Lower than its 5-year historical median
Price to Sales (P/S)
9.47
Lower than its 5-year historical median
EV/EBITDA
13.95
Lower than its 5-year historical median
Dividend Yield
2.71%
Profitability Efficiency
Return on Equity (ROE)
5.27%
Outperforms industry median
Return on Capital Employed (ROCE)
6.28%
Outperforms industry median
Return on Assets (ROA)
4.91%
Operating Profit Margin
37.8%
Net Profit Margin
52.47%
Gross Profit Margin
67.2%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
8.16%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-3.8%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
-12.89%
Asset Quality
Promoter Holding
70.88%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹2,394 Cr.
Equity
₹51.4 Cr.
Face Value
₹2
All Time Low / High
₹0.68 / 169.00
Check Before You Invest
Quality
Not GoodValuation
Somewhat OvervaluedCheck Valuation charts
Price Trend
Semi Strong
Is Alembic Ltd a good quality company?
Alembic Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Alembic Ltd performance compare with that of its Peers?
Revenue growth of Alembic Ltd vs industry peers?
Alembic Ltd revenue CAGR is 24.58%, compared to the industry median CAGR of 0.00%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Alembic Ltd?
Promoters hold 70.88% of the Alembic Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of Alembic Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 9.6% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Alembic Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 3.1% | 4.4% | 3.9% | 7.1% | 0.9% | 4.1% | 3.8% | 4.9% | 7% | 6.3% | - |
| Value Creation Index ⓘ | -0.8 | -0.7 | -0.7 | -0.5 | -0.9 | -0.7 | -0.7 | -0.7 | -0.5 | -0.6 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 147 | 125 | 124 | 73.9 | 73.5 | 78.2 | 127 | 157 | 222 | 240 | 240 |
| Sales YoY Gr. | - | -14.9% | -1.2% | -40.3% | -0.6% | 6.4% | 62.7% | 23.8% | 40.9% | 8.2% | - |
| Adj EPS ⓘ | 5.5 | 6 | 8.3 | 12.8 | 13.2 | 8.5 | 7.7 | 10.4 | 12 | 12.2 | 12.4 |
| YoY Gr. | - | 8% | 38.4% | 54.6% | 3.5% | -35.4% | -10.4% | 36.3% | 14.9% | 2.2% | - |
| BVPS (₹) ⓘ | 34.1 | 40.7 | 47.1 | 55.2 | 89.5 | 97.2 | 80.9 | 85.1 | 91.1 | 95.2 | 95.2 |
| Adj Net Profit ⓘ | 148 | 160 | 212 | 328 | 340 | 219 | 196 | 268 | 308 | 314 | 317 |
| Cash Flow from Ops. ⓘ | 51.6 | 23.6 | 21.5 | 6.5 | -2.2 | -17.8 | 38.9 | 22.7 | 86.4 | 120 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 0 | 0 | -0.1 | 0 | 0 | 0.4 | 0.2 | 0.1 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 5.6% | 26.7% | 23.6% | 8.2% | ||||
| Adj EPS ⓘ | 9.2% | -1.5% | 17% | 2.2% | ||||
| BVPSⓘ | 12.1% | 1.3% | 5.6% | 4.6% | ||||
| Share Price | 9% | -8% | 5.1% | -25.2% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 17.2 | 16 | 18.5 | 25 | 18.3 | 9.2 | 8.6 | 12.6 | 13.6 | 13.1 | 13 |
| Op. Profit Mgn % ⓘ | 4.6 | 8.9 | 14.6 | 4.3 | 14.2 | 17.8 | 31.7 | 36.1 | 42.2 | 37.8 | 37.7 |
| Net Profit Mgn % ⓘ | 20.3 | 30.6 | 32.4 | 124.3 | 14.3 | 106.7 | 67.9 | 58.5 | 63.7 | 51.2 | 132.3 |
| Debt to Equity ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Working Cap Days ⓘ | 248 | 217 | 175 | 258 | 336 | 488 | 370 | 359 | 315 | 278 | 164 |
| Cash Conv. Cycle ⓘ | 168 | 131 | 82 | 110 | 184 | 277 | 227 | 166 | 110 | 96 | 78 |
Profit And Loss
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 147 | 125 | 124 | 74 | 74 | 78 | 127 | 157 | 222 | 240 |
| Operating Expenses ⓘ + | 140 | 114 | 106 | 71 | 63 | 64 | 87 | 101 | 128 | 150 |
| Operating Profit ⓘ | 7 | 11 | 17 | 3 | 10 | 14 | 40 | 57 | 94 | 90 |
| Operating Profit Margin (%) | 4.6% | 8.9% | 14.0% | 4.2% | 14.2% | 17.8% | 31.7% | 36.1% | 42.2% | 37.6% |
| Other Income ⓘ + | 31 | 37 | 30 | 94 | 11 | 89 | 64 | 55 | 75 | 73 |
| Interest ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 2 |
| Depreciation ⓘ | 5 | 4 | 3 | 3 | 4 | 5 | 7 | 8 | 11 | 12 |
| Profit Before Tax ⓘ | 27 | 44 | 45 | 93 | 17 | 98 | 87 | 103 | 156 | 149 |
| Tax ⓘ | -1 | 2 | 4 | 0 | 3 | 12 | 6 | 10 | 11 | 23 |
| Profit After Tax | 27 | 42 | 41 | 93 | 14 | 86 | 81 | 93 | 145 | 126 |
| PAT Margin (%) | 18.7% | 33.4% | 33.2% | 125.9% | 18.8% | 110.2% | 63.4% | 59.0% | 65.2% | 52.5% |
| Adjusted EPS (₹) | 5.4 | 6.1 | 8.3 | 12.8 | 13.4 | 8.7 | 7.4 | 10.5 | 12.1 | 12.4 |
| Dividend Payout Ratio (%) | 3.70% | 3.30% | 2.40% | 4.70% | 1.50% | 20.80% | 29.60% | 22.90% | 19.80% | 19.40% |
Valuation of Alembic - Consolidated
Analyst's Notes
No data found!
Balance Sheet
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 911 | 1,086 | 1,209 | 1,418 | 2,297 | 2,497 | 2,078 | 2,186 | 2,339 | 2,445 | |
| Debt + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7 | 11 | 7 | |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Trade Payables | 15 | 16 | 25 | 13 | 18 | 19 | 17 | 31 | 28 | 24 | |
| Others Liabilities ⓘ | 66 | 57 | 33 | 40 | 94 | 116 | 115 | 111 | 143 | 133 | |
| Total Liabilities ⓘ | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,210 | 2,335 | 2,520 | 2,609 | |
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 148 | 132 | 131 | 131 | 134 | 134 | 132 | 131 | 135 | 170 | |
| CWIP ⓘ | 0 | 32 | 22 | 19 | 37 | 0 | 0 | 1 | 0 | 2 | |
| Investments ⓘ | 732 | 913 | 1,001 | 1,133 | 2,047 | 2,208 | 1,754 | 1,786 | 1,900 | 1,974 | |
| Inventories | 51 | 32 | 35 | 35 | 54 | 87 | 89 | 93 | 99 | 52 | |
| Trade Receivables | 22 | 25 | 14 | 9 | 14 | 15 | 23 | 20 | 30 | 32 | |
| Cash Equivalents | 2 | 1 | 2 | 59 | 7 | 2 | 2 | 2 | 4 | 3 | |
| Others Assets ⓘ | 38 | 24 | 60 | 86 | 116 | 186 | 211 | 302 | 351 | 376 | |
| Total Assets ⓘ | 992 | 1,159 | 1,266 | 1,471 | 2,409 | 2,632 | 2,210 | 2,335 | 2,520 | 2,609 | |
Cash Flow
(All Figures are in Crores.)| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 52 | 24 | 22 | 7 | -2 | -18 | 39 | 23 | 86 | 120 |
| Cash Flow From Investing Activity ⓘ + | -47 | -22 | 72 | 57 | -35 | 19 | 7 | 26 | -27 | -54 |
| Cash Flow From Financing Activity ⓘ | -5 | -3 | -92 | -6 | -15 | -6 | -46 | -48 | -58 | -68 |
| Net Proceeds from Shares ⓘ + | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow ⓘ | -0 | -1 | 1 | 57 | -52 | -5 | -0 | 0 | 1 | -1 |
Financial Ratio
| PARTICULARS | Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 3.21 | 4.18 | 3.58 | 7.08 | 0.75 | 3.6 | 3.52 | 4.36 | 6.39 | 5.27 |
| ROCE (%) | 3.12 | 4.44 | 3.91 | 7.12 | 0.94 | 4.1 | 3.82 | 4.86 | 6.95 | 6.28 |
| Asset Turnover Ratio | 0.16 | 0.12 | 0.1 | 0.05 | 0.04 | 0.03 | 0.05 | 0.07 | 0.09 | 0.09 |
| PAT to CFO Conversion(x) | 1.93 | 0.57 | 0.54 | 0.08 | -0.14 | -0.21 | 0.48 | 0.25 | 0.59 | 0.95 |
| Working Capital Days | ||||||||||
| Receivable Days | 59.10 | 67.30 | 57.20 | 55.50 | 56.60 | 67.70 | 55.50 | 50.10 | 40.90 | 47.10 |
| Inventory Days | 149.70 | 119.20 | 99.80 | 174.60 | 222.70 | 329.30 | 251.70 | 210 | 157.90 | 115.30 |
| Payable Days | 59 | 72.50 | 112.20 | 217.20 | 252.70 | 299.20 | 162.70 | 180.40 | 156.40 | 124.40 |
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Alembic Ltd FAQs
The current trading price of Alembic on 17-Jul-2026 16:59 is ₹88.51.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 16-Jul-2026 the market cap of Alembic stood at ₹2,272.8 Cr
The latest P/E ratio of Alembic as of 16-Jul-2026 is 18.25.
The latest P/B ratio of Alembic as of 16-Jul-2026 is 2.77.
The 52-week high of Alembic is ₹122.4 and the 52-week low is ₹70.64.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Alembic is ₹232 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that Alembic Ltd is a below average quality company.
The key valuation ratios of Alembic Ltd's currently when compared to its past seem to suggest it is in the Somewhat overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Alembic Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.
About Alembic Ltd
Alembic is a Public Limited Company domiciled in India and is incorporated under the provisions of the Companies Act applicable in India. Its shares are listed on two recognised stock exchanges in India. The registered office of the Company is located at Alembic Road, Vadodara, Gujarat. The Company is dealing in Active Pharmaceutical Ingredient (API) Business and Real Estate Business.
Business area of the company
The company is primarily engaged in two businesses i.e.
API Manufacturing
- Estolate
- Biphenyl Valine Oxalate
- Venlafaxine
Real Estate
- Residential Projects
- Commercial Project
You have 3 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
